Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer

In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings. First, subjects who underwent both cancer screening and...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 114; no. 1; pp. 71 - 79
Main Authors Kaji, Kyosuke, Hashiba, Atsushi, Uotani, Chika, Yamaguchi, Yasushi, Ueno, Toshio, Ohno, Kenji, Takabatake, Ichiro, Wakabayashi, Tokio, Doyama, Hisashi, Ninomiya, Itasu, Kiriyama, Masato, Ohyama, Shigekazu, Yoneshima, Manabu, Koyama, Nobu, Takeda, Yasuo, Yasuda, Kenji
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01.01.2019
Subjects
Online AccessGet full text
ISSN0002-9270
1572-0241
1572-0241
DOI10.1038/s41395-018-0259-5

Cover

Abstract In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings. First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined. In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group. Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.
AbstractList OBJECTIVES:In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.METHODS:First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.RESULTS:In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.CONCLUSIONS:Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.
In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings. First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined. In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group. Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.
In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.OBJECTIVESIn order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification is possible using the data obtained from medical examination or endoscopic findings.First, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.METHODSFirst, subjects who underwent both cancer screening and medical examination from 2009 to 2015 and underwent cancer screening once more by 2016 were studied. Data such as the lipid profile and history of smoking obtained during the medical examination, and the grade of atrophy and presence of peptic ulcers were studied using multivariate analysis. Next, subjects who underwent cancer screening twice or more between 2009 and 2015 with or without medical examinations were studied to analyze any correlation between the grade of atrophy and cancer occurrence using univariate analysis. In both studies, the status of Helicobacter pylori (HP) infection was determined.In the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.RESULTSIn the multivariate analysis, 9378 subjects were included. Aging, advanced atrophy, presence of ulcers, and uric acid levels were identified as risk factors. Among subjects who underwent successful HP eradication therapy, advanced atrophy and aging were observed to be crucial risk factors. In the univariate analysis, there were 12,941 subjects. Gastric cancer occurred more frequently in the more severe atrophy group (P < 0.001). The annual rate of cancer occurrence in the most severe atrophy group was 0.31%, which was approximately thrice as that in the less atrophy group.Risk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.CONCLUSIONSRisk stratification was possible based on endoscopic examination alone. The interval should be set depending on each case.
Author Takeda, Yasuo
Ohyama, Shigekazu
Uotani, Chika
Wakabayashi, Tokio
Yamaguchi, Yasushi
Yasuda, Kenji
Ueno, Toshio
Yoneshima, Manabu
Hashiba, Atsushi
Ninomiya, Itasu
Ohno, Kenji
Doyama, Hisashi
Kaji, Kyosuke
Takabatake, Ichiro
Kiriyama, Masato
Koyama, Nobu
Author_xml – sequence: 1
  givenname: Kyosuke
  surname: Kaji
  fullname: Kaji, Kyosuke
– sequence: 2
  givenname: Atsushi
  surname: Hashiba
  fullname: Hashiba, Atsushi
– sequence: 3
  givenname: Chika
  surname: Uotani
  fullname: Uotani, Chika
– sequence: 4
  givenname: Yasushi
  surname: Yamaguchi
  fullname: Yamaguchi, Yasushi
– sequence: 5
  givenname: Toshio
  surname: Ueno
  fullname: Ueno, Toshio
– sequence: 6
  givenname: Kenji
  surname: Ohno
  fullname: Ohno, Kenji
– sequence: 7
  givenname: Ichiro
  surname: Takabatake
  fullname: Takabatake, Ichiro
– sequence: 8
  givenname: Tokio
  surname: Wakabayashi
  fullname: Wakabayashi, Tokio
– sequence: 9
  givenname: Hisashi
  surname: Doyama
  fullname: Doyama, Hisashi
– sequence: 10
  givenname: Itasu
  surname: Ninomiya
  fullname: Ninomiya, Itasu
– sequence: 11
  givenname: Masato
  surname: Kiriyama
  fullname: Kiriyama, Masato
– sequence: 12
  givenname: Shigekazu
  surname: Ohyama
  fullname: Ohyama, Shigekazu
– sequence: 13
  givenname: Manabu
  surname: Yoneshima
  fullname: Yoneshima, Manabu
– sequence: 14
  givenname: Nobu
  surname: Koyama
  fullname: Koyama, Nobu
– sequence: 15
  givenname: Yasuo
  surname: Takeda
  fullname: Takeda, Yasuo
– sequence: 16
  givenname: Kenji
  surname: Yasuda
  fullname: Yasuda, Kenji
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30315306$$D View this record in MEDLINE/PubMed
BookMark eNp9kcFPHCEYxUljU9dt_wAvhsRLL9PywSLM0Wzs1sSkSa1nwjAflXUWVpg5-N-X6aoHDyYEAvm9l4_3TshRTBEJOQX2DZjQ38sKRCsbBrphXLaN_EAWIBWvtxUckQVjjDctV-yYnJSyZQwkV_ITORZMgBTsYkG2m2z7EP_S5OnlmNP-Pji6sWXMYQyF1nVX0E8D9SnT36E80Nsx2zH44OqeIg2RXsU-FZf2VXnrMmKc_Wb-4OPo2kaH-TP56O1Q8MvzuSR3P67-rH82N7821-vLm8bVz4yN4oID73rbes67OqVuNaoONfhOS0Qudc9AodYCW7QdWiaBCwS_UvOLWJKvB999To8TltHsQnE4DDZimorhAG3LL1QNYUnO36DbNOVYpzOCrwSABCkrdfZMTd0Oe7PPYWfzk3lJsQJwAFxOpWT0rwgwMzdlDk2Z2pSZmzKzqXqjcWH8H2nNNwzvKP8BaNSWiQ
CitedBy_id crossref_primary_10_1186_s12876_020_01375_z
crossref_primary_10_1097_MD_0000000000033942
crossref_primary_10_1111_1751_2980_13193
crossref_primary_10_1159_000538941
crossref_primary_10_1038_s41598_023_47000_3
crossref_primary_10_1080_17474124_2020_1770594
crossref_primary_10_1080_00365521_2022_2089859
crossref_primary_10_1016_j_gie_2019_05_034
crossref_primary_10_1007_s00535_024_02139_2
crossref_primary_10_1111_hel_13056
crossref_primary_10_1016_j_dld_2019_12_146
crossref_primary_10_5009_gnl210313
crossref_primary_10_1007_s10620_020_06813_2
crossref_primary_10_1111_jgh_15396
crossref_primary_10_3390_cancers16122254
crossref_primary_10_1016_j_ebiom_2023_104844
crossref_primary_10_14309_ajg_0000000000000709
crossref_primary_10_3748_wjg_v26_i5_466
crossref_primary_10_1111_den_14118
crossref_primary_10_3390_jcm11123550
crossref_primary_10_3748_wjg_v27_i18_2238
crossref_primary_10_1007_s10120_023_01413_1
crossref_primary_10_1159_000529814
crossref_primary_10_1080_00365521_2020_1740777
crossref_primary_10_5946_ce_2019_072
crossref_primary_10_1111_hel_12669
crossref_primary_10_12998_wjcc_v8_i14_2902
crossref_primary_10_3390_biomedicines10030556
crossref_primary_10_7704_kjhugr_2023_0013
crossref_primary_10_1055_a_1662_5150
crossref_primary_10_1007_s10620_021_07086_z
crossref_primary_10_4103_sjg_sjg_206_21
crossref_primary_10_37126_aige_v4_i1_1
crossref_primary_10_3390_cancers16244153
crossref_primary_10_1007_s10388_021_00822_4
crossref_primary_10_1002_jgh3_12360
crossref_primary_10_1007_s00011_021_01501_x
crossref_primary_10_1007_s00535_019_01577_7
crossref_primary_10_1016_j_dld_2022_04_025
crossref_primary_10_1080_00365521_2022_2055974
crossref_primary_10_1111_jgh_15693
crossref_primary_10_4253_wjge_v17_i3_99540
crossref_primary_10_1111_jgh_15177
crossref_primary_10_3390_diagnostics11081305
crossref_primary_10_1111_jgh_15282
crossref_primary_10_1080_17474124_2024_2395317
crossref_primary_10_3748_wjg_v29_i31_4763
crossref_primary_10_3748_wjg_v28_i43_6078
crossref_primary_10_3390_ijms26010275
crossref_primary_10_3164_jcbn_20_67
crossref_primary_10_1159_000516561
crossref_primary_10_3390_jcm11154337
crossref_primary_10_3390_jcm13061587
crossref_primary_10_1080_00365521_2023_2220854
crossref_primary_10_7704_kjhugr_2020_0010
Cites_doi 10.1002/ijc.10649
10.1055/s-0028-1098086
10.1016/j.cgh.2014.07.043
10.1002/ijc.22157
10.3748/wjg.v21.i46.13113
10.1016/j.gie.2016.03.791
10.1002/ijc.2910560407
10.1007/s10620-010-1154-0
10.1111/cas.12821
10.1080/003655298750027074
10.1111/j.1349-7006.1995.tb03001.x
10.1111/den.12471
10.1067/mge.2001.114422
10.1111/j.1572-0241.2006.01109.x
10.1007/s00535-006-1924-9
10.1002/ijc.20518
ContentType Journal Article
Copyright 2018 by The American College of Gastroenterology
Copyright_xml – notice: 2018 by The American College of Gastroenterology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1038/s41395-018-0259-5
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
ProQuest Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest One Academic Middle East (New)
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: ProQuest Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1572-0241
EndPage 79
ExternalDocumentID 30315306
10_1038_s41395_018_0259_5
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
--K
-Q-
.55
.GJ
0R~
123
1B1
1OC
23M
31~
36B
39C
3O-
4.4
4G.
53G
5RE
5VS
6J9
70F
7X7
88E
8FI
8FJ
8GM
AAAAV
AAEDT
AAGIX
AAHPQ
AAIQE
AAJCS
AALRI
AAMOA
AAQFI
AAQKA
AAQQT
AAQXK
AASCR
AASXQ
AAXUO
AAYXX
ABASU
ABAWZ
ABDIG
ABJNI
ABLJU
ABOCM
ABPXF
ABUWG
ABVCZ
ABWVN
ABXYN
ABZZY
ACGFO
ACGFS
ACILI
ACKTT
ACLDA
ACNWC
ACOAL
ACRPL
ACXJB
ACXQS
ACZKN
ADBBV
ADFRT
ADGGA
ADHPY
ADKSD
ADMUD
ADNKB
ADNMO
ADSXY
AEBDS
AEETU
AENEX
AEXYK
AFBFQ
AFBPY
AFDTB
AFEBI
AFEXH
AFFNX
AFKRA
AFNMH
AFUWQ
AGAYW
AGQPQ
AHMBA
AHOMT
AHQNM
AHQVU
AHSBF
AHVBC
AI.
AINUH
AJAOE
AJCLO
AJIOK
AJNWD
AJRNO
AJZMW
AKCTQ
AKRWK
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BENPR
BPHCQ
BVXVI
BYPQX
C45
CAG
CCPQU
CITATION
COF
CS3
DIWNM
EBS
EE.
EEVPB
EJD
EMB
EMOBN
ERAAH
F5P
FCALG
FDB
FDQFY
FEDTE
FGOYB
FYUFA
GNXGY
GQDEL
HLJTE
HMCUK
HVGLF
HZ~
IHE
IKREB
IKYAY
IPNFZ
JSO
LH4
LW6
M1P
M41
N4W
NQ-
O9-
ODMTH
OPUJH
OVD
OVDNE
P0W
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
R2-
RIG
RLZ
RNT
RNTTT
ROL
RPZ
SEW
SJN
SSZ
SV3
TEORI
TSPGW
UDS
UKHRP
VH1
X7M
XIF
XPP
ZGI
ZXP
ZZMQN
3V.
AAYOK
ACIJW
ALIPV
CGR
CUY
CVF
ECM
EIF
NPM
SNX
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c395t-723212bda9f22b530898e7be81fb85ee258d017e883e9eabea05123e1f473e9e3
IEDL.DBID 7X7
ISSN 0002-9270
1572-0241
IngestDate Mon Sep 08 11:38:11 EDT 2025
Tue Aug 26 04:12:29 EDT 2025
Wed Feb 19 02:31:36 EST 2025
Thu Apr 24 23:07:17 EDT 2025
Wed Oct 01 06:01:32 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-723212bda9f22b530898e7be81fb85ee258d017e883e9eabea05123e1f473e9e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 30315306
PQID 3243115155
PQPubID 2041977
PageCount 9
ParticipantIDs proquest_miscellaneous_2119926730
proquest_journals_3243115155
pubmed_primary_30315306
crossref_primary_10_1038_s41395_018_0259_5
crossref_citationtrail_10_1038_s41395_018_0259_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-01-00
20190101
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle The American journal of gastroenterology
PublicationTitleAlternate Am J Gastroenterol
PublicationYear 2019
Publisher Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Publisher_xml – name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
References Lee (R5-20250611) 2015; 13
Hsu (R12-20250611) 2007; 102
Koizumi (R4-20250611) 2004; 112
Shichijo (R13-20250611) 2016; 84
Take (R8-20250611) 2007; 42
Furuta (R10-20250611) 1998; 33
Kimura (R9-20250611) 1969; 3
Kato (R3-20250611) 1990; 50
Sasazuki (R6-20250611) 2002; 101
Sjodahl (R7-20250611) 2007; 120
Sieg (R19-20250611) 2001; 53
Yamamoto (R17-20250611) 2015; 27
Nomura (R16-20250611) 1995; 86
Inoue (R2-20250611) 1994; 56
Kono (R14-20250611) 2015; 21
Mizuno (R15-20250611) 2010; 55
Watanabe (R18-20250611) 2015; 106
30676379 - Am J Gastroenterol. 2019 Apr;114(4):690
30789415 - Am J Gastroenterol. 2019 Apr;114(4):690-691
30844907 - Am J Gastroenterol. 2019 May;114(5):836
References_xml – volume: 101
  start-page: 560
  year: 2002
  ident: R6-20250611
  article-title: Cigarette smoking, alcohol consumption and subsequent gastric cancer risk by subsite and histologic type
  publication-title: Int J Cancer
  doi: 10.1002/ijc.10649
– volume: 3
  start-page: 87
  year: 1969
  ident: R9-20250611
  article-title: An endoscopic recognition of the atrophic border and its significance in chronic gastritis
  publication-title: Eodoscopy
  doi: 10.1055/s-0028-1098086
– volume: 13
  start-page: 287
  year: 2015
  ident: R5-20250611
  article-title: A tool to predict risk for gastric cancer in patients with peptic ulcer disease on the basis of a nationwide cohort
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2014.07.043
– volume: 120
  start-page: 128
  year: 2007
  ident: R7-20250611
  article-title: Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22157
– volume: 21
  start-page: 13113
  year: 2015
  ident: R14-20250611
  article-title: Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v21.i46.13113
– volume: 84
  start-page: 618
  year: 2016
  ident: R13-20250611
  article-title: Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2016.03.791
– volume: 56
  start-page: 494
  year: 1994
  ident: R2-20250611
  article-title: Life-style and subsite of gastric cancer–joint effect of smoking and drinking habits
  publication-title: Int J Cancer
  doi: 10.1002/ijc.2910560407
– volume: 55
  start-page: 3132
  year: 2010
  ident: R15-20250611
  article-title: Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-010-1154-0
– volume: 50
  start-page: 6559
  year: 1990
  ident: R3-20250611
  article-title: A comparative case-control analysis of stomach cancer and atrophic gastritis
  publication-title: Cancer Res
– volume: 106
  start-page: 1738
  year: 2015
  ident: R18-20250611
  article-title: Declining trends in prevalence of Helicobacter pylori infection by birth-year in a Japanese population
  publication-title: Cancer Sci
  doi: 10.1111/cas.12821
– volume: 33
  start-page: 1005
  year: 1998
  ident: R10-20250611
  article-title: Helicobacter pylori infection and progression of gastric atrophy and intestinal metaplasia
  publication-title: Scand J Gastroenterol
  doi: 10.1080/003655298750027074
– volume: 86
  start-page: 916
  year: 1995
  ident: R16-20250611
  article-title: Gastric cancer among the Japanese in Hawaii
  publication-title: Jpn J Cancer Res
  doi: 10.1111/j.1349-7006.1995.tb03001.x
– volume: 27
  start-page: 551
  year: 2015
  ident: R17-20250611
  article-title: Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings
  publication-title: Dig Endosc
  doi: 10.1111/den.12471
– volume: 53
  start-page: 620
  year: 2001
  ident: R19-20250611
  article-title: Prospective evaluation of complications in outpatient GI endoscopy: a survey among German gastroenterologists
  publication-title: Gastrointest Endosc
  doi: 10.1067/mge.2001.114422
– volume: 102
  start-page: 725
  year: 2007
  ident: R12-20250611
  article-title: Helicobacter pylori infection and the risk of gastric malignancy
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.2006.01109.x
– volume: 42
  start-page: 21
  issue: Suppl 17
  year: 2007
  ident: R8-20250611
  article-title: Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-006-1924-9
– volume: 112
  start-page: 1049
  year: 2004
  ident: R4-20250611
  article-title: Cigarette smoking and the risk of gastric cancer: a pooled analysis of two prospective studies in Japan
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20518
– reference: 30676379 - Am J Gastroenterol. 2019 Apr;114(4):690
– reference: 30844907 - Am J Gastroenterol. 2019 May;114(5):836
– reference: 30789415 - Am J Gastroenterol. 2019 Apr;114(4):690-691
SSID ssj0015275
Score 2.5180318
Snippet In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk stratification...
OBJECTIVES:In order to screen for gastric cancer effectively, its interval should be set according to the risk. This study aimed to determine whether risk...
SourceID proquest
pubmed
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 71
SubjectTerms Adult
Aged
Cholesterol
Committees
Endoscopy
Female
Females
Gastric cancer
Gastritis, Atrophic - diagnostic imaging
Gastritis, Atrophic - epidemiology
Gastritis, Atrophic - microbiology
Gastritis, Atrophic - pathology
Gastroscopy
Helicobacter Infections - diagnostic imaging
Helicobacter Infections - epidemiology
Helicobacter Infections - microbiology
Helicobacter Infections - pathology
Helicobacter pylori - isolation & purification
Hemoglobin
Humans
Infections
Japan - epidemiology
Male
Medical screening
Metabolic syndrome
Middle Aged
Neoplasm Grading
Risk Factors
Stomach Neoplasms - diagnostic imaging
Stomach Neoplasms - epidemiology
Stomach Neoplasms - microbiology
Stomach Neoplasms - pathology
Ulcers
Uric acid
Title Grading of Atrophic Gastritis is Useful for Risk Stratification in Endoscopic Screening for Gastric Cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/30315306
https://www.proquest.com/docview/3243115155
https://www.proquest.com/docview/2119926730
Volume 114
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: Elsevier Journals
  customDbUrl:
  mediaType: online
  eissn: 1572-0241
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0015275
  issn: 0002-9270
  databaseCode: AKRWK
  dateStart: 19980101
  isFulltext: true
  providerName: Library Specific Holdings
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swED-2FsZexr6Xrisa7GkgGtlWLD2NrKQtKy0jW1jehCRLLFuxszj5_3snOx57WMFgsCUZ34fuJ93pDuCDrsaFFyLyYJ3jhbKCW7RDPCCWdU6EiUse_OubyeWi-LKUy37Dre3DKvdzYpqoq8bTHvkpGn5KDIPm79P6D6eqUeRd7UtoPIRDgVCFpLpcDgsuqtgq9_BXZ-Xg1czVaYuTN51NFoqj1ddc_muX_gM2k9E5fwpPerTIph17n8GDUD-HR9e9P_wF_LrYpBh41kQ23W6a9c-VZxe2TRn2W4bXog1xd8sQmrL5qv3NUjZaCg9KHGGrms3qqqGzKdjzm6coHBqP2nfjeHZGgrF5CYvz2fezS95XT-Ae_2zLS8RKInOV1THLnMzHSqtQuqBEdEqGkElVoToGpfKgkVPBon5meRCxKOlJ_goO6qYOb4BZiWrvnNTK60LE6ApbeVFEYUPuMu1GMN7Tzvg-tThVuLg1ycWdK9OR2yC5DZHbyBF8HLqsu7wa9zU-3jPE9CrWmr8CMYL3w2tUDvJ42Do0u9ZQ-jqdTXAWG8HrjpHD13Kqb4ELpqP7B38LjxEj6W7X5RgOtptdeIc4ZOtOkrCdwOH0av7jCu-fZzdf53eTqdyJ
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgEXxLMsFDASXJCsru141z4gVJW2W9rtAbrS3oydOGKhSpbNrhB_it_ITF6IA71VyimxJ8r4i-ezZzwD8NpmwyQVIufRh8AT4wX3aId4RC4bgoijUHvwp-ejySz5ONfzLfjdnYWhsMpuTqwn6qxMaY98Dw0_JYZB8_d--YNT1SjyrnYlNBpYnMZfP3HJVr07-YDj-0bKo8OLgwlvqwrwVFm95mPkEEKGzNtcyqDV0FgTxyEakQejY5TaZAjTaIyKFr8gesStVFHkyZjuKJR7A24maphQrv7xvF_gUYVY3dFtK8e9F1WZvQqNBZ2FFoYjy7Bc_2sH_0NuayN3dA_utuyU7Tdwug9bsXgAt6at__0hfDte1TH3rMzZ_npVLr8uUnbsqzqjf8XwmlUx31wypMLs06L6zurstxSOVCOALQp2WGQlnYXBnp9TivohedS-kZOyAwLi6hHMrkWvj2G7KIv4BJjXOM2EoK1JbSLyPCQ-S0WSCx9VkDYMYNjpzqVtKnOqqHHpape6Mq5Rt0N1O1K30wN423dZNnk8rmq82w2Ia3_pyv0F4ABe9Y_xZyQPiy9iuakcpcuzcoSz5gB2moHs36aongYu0J5eLfwl3J5cTM_c2cn56TO4g_zMNjs-u7C9Xm3ic-RA6_CiBh6DL9eN9D92LhYd
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEG8WChgJLkjWru14Yx8QqtpuW0orBKy0N2MnjlhAybLZCvHX-HXM5IU40FulnBJ7ooy_eD57xjMAL2w-STIhCh59CDwxXnCPdohH5LIhiDgNjQf_7Hx6PE_eLvRiC373Z2EorLKfE5uJOq8y2iMfo-GnxDBo_sZFFxbx_mD2ZvWDUwUp8rT25TRaiJzGXz9x-Va_PjnAsX4p5ezw0_4x7yoM8ExZveEp8gkhQ-5tIWXQamKsiWmIRhTB6BilNjlCNhqjosWviR4xLFUURZLSHYVyr8H1VCWKwsnSxbDYo2qxuqfeVqaDR1WZcY2Gg85FC8ORcViu_7WJ_yG6jcGb3YKbHVNley20bsNWLO_Azlnni78LX4_WTfw9qwq2t1lXqy_LjB35usnuXzO85nVEJTKkxezDsv7Gmky4FJrUoIEtS3ZY5hWdi8GeHzOKACJ51L6Vk7F9AuX6HsyvRK_3YbusyvgQmNc45YSgrclsIooiJD7PRFIIH1WQNoxg0uvOZV1ac6qu8d017nVlXKtuh-p2pG6nR_Bq6LJqc3pc1ni3HxDX_d61-wvGETwfHuOPSd4WX8bqonaUOs_KKc6gI3jQDuTwNkW1NXCx9uhy4c9gBzHu3p2cnz6GG0jVbLv5swvbm_VFfIJ0aBOeNrhj8Pmqgf4Hch8aWA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Grading+of+Atrophic+Gastritis+is+Useful+for+Risk+Stratification+in+Endoscopic+Screening+for+Gastric+Cancer&rft.jtitle=The+American+journal+of+gastroenterology&rft.au=Kaji%2C+Kyosuke&rft.au=Hashiba%2C+Atsushi&rft.au=Uotani%2C+Chika&rft.au=Yamaguchi%2C+Yasushi&rft.date=2019-01-01&rft.issn=1572-0241&rft.eissn=1572-0241&rft.volume=114&rft.issue=1&rft.spage=71&rft_id=info:doi/10.1038%2Fs41395-018-0259-5&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9270&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9270&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9270&client=summon